Skip to main content

Upcoming presentations/meetings

2024-03-07
Swiss Nordic Bio 2024, Zurich, March 7
2024-03-08
AAD Annual Meeting, San Diego, March 8-12
2024-03-18
Bio Europe Spring, Barcelona, March 18-20
2024-05-07
Interim report for January - March 2024
2024-05-14
Annual General Meeting of Moberg Pharma

The annual general meeting for Moberg Pharma will be held on May 14, 2024. The last date for shareholders to submit requests for consideration at the annual general meeting is March 26, 2024. The annual report will be available no later than April 16, 2024 on the company's website www.mobergpharma.se

2024-05-16
Redeye Investor Forum Online
2024-05-30
Redeye Growth Day
2024-06-03
Bio International Convention, San Diego, June 3-6
2024-08-13
Interim report for January - June 2024
2024-08-29
Redeye Investor Forum Online
2024-11-12
Interim report for January - September 2024
2024-11-13
Redeye Investor Forum
2024-12-05
Redeye Life Science Day

Previous presentations/meetings

2024-02-13
Year-end report 2023
2023-11-23
Redeye Life Science Day
2023-11-07
Interim report för January - September 2023
2023-11-06
Bio-Europe, Munich
2023-08-31
Redeye Investor Forum Online
2023-08-24
Videointerview about launch plans and rights issue
2023-08-18
Article in BioStock
2023-08-03
Interim report for January - June 2023
2023-08-01
Presentation of Moberg Pharma
2023-06-01
Redeye Growth Day
2023-05-16
Annual General Meeting of Moberg Pharma
2023-05-16
Annual General Meeting of Moberg Pharma
2023-05-09
Interim report for January - March 2023
2023-03-30
Swiss Nordic Bio, Zürich
2023-03-17
AAD Annual Meeting, New Orleans
2023-03-07
Redeye Investor Forum
2023-02-07
Year-end report 2022
2022-11-24
Redeye Life Science Day
2022-11-15
CEO Interview with Anna Ljung
2022-11-08
Interim report for January - September 2022
2022-09-01
Redeye Investor Forum
2022-08-31
Aktiespararnas digital Life Science Day
2022-08-09
Interim report for January - June 2022
2022-08-09
CEO Interview with Anna Ljung
2022-05-10
CEO Interview with Anna Ljung
2022-05-10
Interim report for January - March 2022
2022-05-05
Redeye Investor Forum
2022-03-25
AAD Annual Meeting, Boston, MA, 25-29 March
2022-03-08
SCF Life Science Corporate Finance Day, Stockholm
2022-02-24
Redeye Investor Forum
2022-02-09
CEO Interview with Anna Ljung
2022-02-08
Year-end report for the financial year 2021
2021-12-09
Redeye Investor Forum
2021-11-11
Redeye Life Science Day
2021-11-09
CEO Interview with Anna Ljung

 

2021-11-09
Interim report for January - September 2021

2021-10-07
Vator Securities - Healthcare Innovation Summit
2021-09-02
Redeye Investor Forum
2021-09-01
Pareto Securities Annual Healthcare Conference
2021-08-10
Interim report for January - June 2021

2021-06-02
Redeye Growth Day
2021-05-26
BioStock Life Science Summit
2021-05-11
Redeye Investor Forum
2021-05-11
CEO Interview with Anna Ljung

2021-05-11
Interim report for January - March 2021

2021-03-25
Redeye Investor Forum
2021-02-10
Swiss Nordic Bio 2021